BR112020009254A2

BR112020009254A2 - método para prevenir ou tratar um distúrbio mucósico no intestino e/ou pulmão de um bebê prematuro, peptídeo antimicrobiano, polipeptídeo de defensina, e, uso de um polipeptídeo de defensina para a fabricação de um medicamento

método para prevenir ou tratar um distúrbio mucósico no intestino e/ou pulmão de um bebê prematuro, peptídeo antimicrobiano, polipeptídeo de defensina, e, uso de um polipeptídeo de defensina para a fabricação de um medicamento Download PDF

Info

Publication number: BR112020009254A2
Authority: BR; Brazil
Prior art keywords: hdm; vehicle; saline; day; hbd
Prior art date: 2017-11-10

Application number

BR112020009254-1A

Other languages

English (en)

Portuguese (pt)

Inventor

Peter Norkild

Original Assignee

Defensin Therapeutics Aps

Priority date

2017-11-10

Filing date

2018-11-09

Publication date

2020-10-27

2018-11-09 Application filed by Defensin Therapeutics Aps filed Critical Defensin Therapeutics Aps

2020-10-27 Publication of BR112020009254A2 publication Critical patent/BR112020009254A2/pt

Links

206010036590 Premature baby Diseases 0.000 title claims abstract description 164
102000044503 Antimicrobial Peptides Human genes 0.000 title claims abstract description 78
108700042778 Antimicrobial Peptides Proteins 0.000 title claims abstract description 78
239000003910 polypeptide antibiotic agent Substances 0.000 title claims abstract description 60
102000000541 Defensins Human genes 0.000 title claims description 116
108010002069 Defensins Proteins 0.000 title claims description 116
210000004072 lung Anatomy 0.000 title claims description 92
210000000936 intestine Anatomy 0.000 title claims description 42
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims description 33
238000004519 manufacturing process Methods 0.000 title claims description 17
239000003814 drug Substances 0.000 title claims description 13
238000000034 method Methods 0.000 title abstract description 121
229940079593 drug Drugs 0.000 title description 6
238000011282 treatment Methods 0.000 claims abstract description 75
208000004995 necrotizing enterocolitis Diseases 0.000 claims abstract description 69
206010051606 Necrotising colitis Diseases 0.000 claims abstract description 68
201000006195 perinatal necrotizing enterocolitis Diseases 0.000 claims abstract description 68
230000002265 prevention Effects 0.000 claims abstract description 23
206010049416 Short-bowel syndrome Diseases 0.000 claims abstract description 16
208000023504 respiratory system disease Diseases 0.000 claims abstract description 16
238000007920 subcutaneous administration Methods 0.000 claims abstract description 15
230000001154 acute effect Effects 0.000 claims abstract description 10
230000002035 prolonged effect Effects 0.000 claims abstract description 10
TWSALRJGPBVBQU-PKQQPRCHSA-N glucagon-like peptide 2 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O)[C@@H](C)CC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=CC=C1 TWSALRJGPBVBQU-PKQQPRCHSA-N 0.000 claims abstract description 9
206010012735 Diarrhoea Diseases 0.000 claims abstract description 8
208000004756 Respiratory Insufficiency Diseases 0.000 claims abstract description 7
206010057190 Respiratory tract infections Diseases 0.000 claims abstract description 7
201000004193 respiratory failure Diseases 0.000 claims abstract description 7
102400000326 Glucagon-like peptide 2 Human genes 0.000 claims abstract description 6
101800000221 Glucagon-like peptide 2 Proteins 0.000 claims abstract description 6
101000884714 Homo sapiens Beta-defensin 4A Proteins 0.000 claims description 187
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 71
230000002685 pulmonary effect Effects 0.000 claims description 62
239000011780 sodium chloride Substances 0.000 claims description 51
210000004027 cell Anatomy 0.000 claims description 50
230000000694 effects Effects 0.000 claims description 50
239000000203 mixture Substances 0.000 claims description 49
238000012360 testing method Methods 0.000 claims description 49
238000011081 inoculation Methods 0.000 claims description 40
108090000765 processed proteins & peptides Proteins 0.000 claims description 37
210000001072 colon Anatomy 0.000 claims description 34
-1 for example Proteins 0.000 claims description 33
235000009200 high fat diet Nutrition 0.000 claims description 32
230000001225 therapeutic effect Effects 0.000 claims description 30
206010061218 Inflammation Diseases 0.000 claims description 29
230000004054 inflammatory process Effects 0.000 claims description 29
102000004127 Cytokines Human genes 0.000 claims description 28
108090000695 Cytokines Proteins 0.000 claims description 28
241000894006 Bacteria Species 0.000 claims description 25
206010035664 Pneumonia Diseases 0.000 claims description 25
210000000813 small intestine Anatomy 0.000 claims description 24
235000005911 diet Nutrition 0.000 claims description 21
230000037213 diet Effects 0.000 claims description 21
102100038326 Beta-defensin 4A Human genes 0.000 claims description 20
208000035475 disorder Diseases 0.000 claims description 18
229960003957 dexamethasone Drugs 0.000 claims description 17
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims description 17
101000952040 Homo sapiens Beta-defensin 1 Proteins 0.000 claims description 16
210000000440 neutrophil Anatomy 0.000 claims description 15
102100037437 Beta-defensin 1 Human genes 0.000 claims description 13
210000003979 eosinophil Anatomy 0.000 claims description 13
210000002540 macrophage Anatomy 0.000 claims description 13
108010088751 Albumins Proteins 0.000 claims description 12
102000009027 Albumins Human genes 0.000 claims description 12
238000011161 development Methods 0.000 claims description 12
210000000265 leukocyte Anatomy 0.000 claims description 12
230000000069 prophylactic effect Effects 0.000 claims description 12
102100026886 Beta-defensin 104 Human genes 0.000 claims description 11
101000912243 Homo sapiens Beta-defensin 104 Proteins 0.000 claims description 11
235000015263 low fat diet Nutrition 0.000 claims description 11
230000004048 modification Effects 0.000 claims description 11
238000012986 modification Methods 0.000 claims description 11
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 10
239000003242 anti bacterial agent Substances 0.000 claims description 10
229940088710 antibiotic agent Drugs 0.000 claims description 10
239000006041 probiotic Substances 0.000 claims description 10
235000018291 probiotics Nutrition 0.000 claims description 10
239000004094 surface-active agent Substances 0.000 claims description 10
210000004185 liver Anatomy 0.000 claims description 9
150000001875 compounds Chemical class 0.000 claims description 8
230000004083 survival effect Effects 0.000 claims description 8
206010001052 Acute respiratory distress syndrome Diseases 0.000 claims description 7
208000013616 Respiratory Distress Syndrome Diseases 0.000 claims description 7
206010006475 bronchopulmonary dysplasia Diseases 0.000 claims description 7
238000005259 measurement Methods 0.000 claims description 7
230000003448 neutrophilic effect Effects 0.000 claims description 7
238000001990 intravenous administration Methods 0.000 claims description 6
235000004213 low-fat Nutrition 0.000 claims description 6
NZWOPGCLSHLLPA-UHFFFAOYSA-N methacholine Chemical compound C[N+](C)(C)CC(C)OC(C)=O NZWOPGCLSHLLPA-UHFFFAOYSA-N 0.000 claims description 6
229960002329 methacholine Drugs 0.000 claims description 6
238000012546 transfer Methods 0.000 claims description 6
GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims description 5
206010070834 Sensitisation Diseases 0.000 claims description 5
210000004369 blood Anatomy 0.000 claims description 5
239000008280 blood Substances 0.000 claims description 5
210000000981 epithelium Anatomy 0.000 claims description 5
210000003608 fece Anatomy 0.000 claims description 5
210000004698 lymphocyte Anatomy 0.000 claims description 5
229920000642 polymer Polymers 0.000 claims description 5
238000005070 sampling Methods 0.000 claims description 5
230000008313 sensitization Effects 0.000 claims description 5
102000020313 Cell-Penetrating Peptides Human genes 0.000 claims description 4
108010051109 Cell-Penetrating Peptides Proteins 0.000 claims description 4
235000021068 Western diet Nutrition 0.000 claims description 4
230000004913 activation Effects 0.000 claims description 4
230000002500 effect on skin Effects 0.000 claims description 4
229960003444 immunosuppressant agent Drugs 0.000 claims description 4
239000003018 immunosuppressive agent Substances 0.000 claims description 4
238000007917 intracranial administration Methods 0.000 claims description 4
230000005012 migration Effects 0.000 claims description 4
238000013508 migration Methods 0.000 claims description 4
235000013406 prebiotics Nutrition 0.000 claims description 4
206010003598 Atelectasis Diseases 0.000 claims description 3
208000007123 Pulmonary Atelectasis Diseases 0.000 claims description 3
102000004338 Transferrin Human genes 0.000 claims description 3
108090000901 Transferrin Proteins 0.000 claims description 3
208000008784 apnea Diseases 0.000 claims description 3
230000003833 cell viability Effects 0.000 claims description 3
239000003862 glucocorticoid Substances 0.000 claims description 3
230000003993 interaction Effects 0.000 claims description 3
210000003914 myeloid leukocyte Anatomy 0.000 claims description 3
230000000414 obstructive effect Effects 0.000 claims description 3
229940037128 systemic glucocorticoids Drugs 0.000 claims description 3
239000012581 transferrin Substances 0.000 claims description 3
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
239000002253 acid Substances 0.000 claims description 2
229920002674 hyaluronan Polymers 0.000 claims description 2
229960003160 hyaluronic acid Drugs 0.000 claims description 2
230000000638 stimulation Effects 0.000 claims description 2
230000007838 tissue remodeling Effects 0.000 claims description 2
230000000112 colonic effect Effects 0.000 claims 7
210000004400 mucous membrane Anatomy 0.000 claims 6
101800005309 Carboxy-terminal peptide Proteins 0.000 claims 2
102100031196 Choriogonadotropin subunit beta 3 Human genes 0.000 claims 2
101000776619 Homo sapiens Choriogonadotropin subunit beta 3 Proteins 0.000 claims 2
102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 claims 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
238000012353 t test Methods 0.000 claims 2
102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 1
108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 1
101710177940 IgG receptor FcRn large subunit p51 Proteins 0.000 claims 1
102000004877 Insulin Human genes 0.000 claims 1
108090001061 Insulin Proteins 0.000 claims 1
101710186630 Insulin-1 Proteins 0.000 claims 1
102000043136 MAP kinase family Human genes 0.000 claims 1
108091054455 MAP kinase family Proteins 0.000 claims 1
PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 claims 1
239000006146 Roswell Park Memorial Institute medium Substances 0.000 claims 1
241000191967 Staphylococcus aureus Species 0.000 claims 1
230000033228 biological regulation Effects 0.000 claims 1
230000021164 cell adhesion Effects 0.000 claims 1
230000017455 cell-cell adhesion Effects 0.000 claims 1
230000004069 differentiation Effects 0.000 claims 1
238000005265 energy consumption Methods 0.000 claims 1
210000002744 extracellular matrix Anatomy 0.000 claims 1
230000025952 extracellular structure organization Effects 0.000 claims 1
210000003958 hematopoietic stem cell Anatomy 0.000 claims 1
229940125396 insulin Drugs 0.000 claims 1
102000006495 integrins Human genes 0.000 claims 1
108010044426 integrins Proteins 0.000 claims 1
201000004792 malaria Diseases 0.000 claims 1
239000006199 nebulizer Substances 0.000 claims 1
108010068617 neonatal Fc receptor Proteins 0.000 claims 1
230000008520 organization Effects 0.000 claims 1
230000029504 positive regulation of cell motility Effects 0.000 claims 1
230000016412 positive regulation of cytokine production Effects 0.000 claims 1
230000024715 positive regulation of secretion Effects 0.000 claims 1
230000011664 signaling Effects 0.000 claims 1
208000010110 spontaneous platelet aggregation Diseases 0.000 claims 1
239000006200 vaporizer Substances 0.000 claims 1
210000005166 vasculature Anatomy 0.000 claims 1
230000029663 wound healing Effects 0.000 claims 1
235000021242 lactoferrin Nutrition 0.000 abstract description 111
235000010335 lysozyme Nutrition 0.000 abstract description 108
102000018568 alpha-Defensin Human genes 0.000 abstract description 97
108050007802 alpha-defensin Proteins 0.000 abstract description 97
102000012265 beta-defensin Human genes 0.000 abstract description 97
108050002883 beta-defensin Proteins 0.000 abstract description 97
230000032696 parturition Effects 0.000 abstract description 42
206010040047 Sepsis Diseases 0.000 abstract description 33
208000013223 septicemia Diseases 0.000 abstract description 33
108060001132 cathelicidin Proteins 0.000 abstract description 23
102000014509 cathelicidin Human genes 0.000 abstract description 23
230000012010 growth Effects 0.000 abstract description 22
230000001771 impaired effect Effects 0.000 abstract description 16
210000000987 immune system Anatomy 0.000 abstract description 14
230000007472 neurodevelopment Effects 0.000 abstract description 10
206010050685 Cytokine storm Diseases 0.000 abstract description 4
206010052015 cytokine release syndrome Diseases 0.000 abstract description 4
230000008881 mucosal defense Effects 0.000 abstract description 4
102000049262 human DEFB4A Human genes 0.000 description 167
241000699670 Mus sp. Species 0.000 description 86
108050004676 Histone deacetylase 5 Proteins 0.000 description 56
102100021453 Histone deacetylase 5 Human genes 0.000 description 56
108010063045 Lactoferrin Proteins 0.000 description 53
102000010445 Lactoferrin Human genes 0.000 description 53
CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 53
229940078795 lactoferrin Drugs 0.000 description 53
108010014251 Muramidase Proteins 0.000 description 49
102000016943 Muramidase Human genes 0.000 description 49
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 48
230000000968 intestinal effect Effects 0.000 description 48
101800004361 Lactoferricin-B Proteins 0.000 description 47
CFFMZOZGXDAXHP-HOKBLYKWSA-N lactoferricin Chemical compound C([C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(=O)N[C@H](C(N[C@H](C(=O)N1)[C@@H](C)O)=O)[C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CFFMZOZGXDAXHP-HOKBLYKWSA-N 0.000 description 47
239000004325 lysozyme Substances 0.000 description 47
229960000274 lysozyme Drugs 0.000 description 47
208000006673 asthma Diseases 0.000 description 41
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 40
239000002953 phosphate buffered saline Substances 0.000 description 40
239000000428 dust Substances 0.000 description 39
241000736262 Microbiota Species 0.000 description 36
108060008682 Tumor Necrosis Factor Proteins 0.000 description 34
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 34
230000037396 body weight Effects 0.000 description 33
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 32
241001529936 Murinae Species 0.000 description 30
235000001014 amino acid Nutrition 0.000 description 30
150000001413 amino acids Chemical class 0.000 description 30
150000003431 steroids Chemical class 0.000 description 28
229940024606 amino acid Drugs 0.000 description 27
210000001519 tissue Anatomy 0.000 description 27
238000010172 mouse model Methods 0.000 description 26
210000001744 T-lymphocyte Anatomy 0.000 description 25
238000011321 prophylaxis Methods 0.000 description 24
108090001005 Interleukin-6 Proteins 0.000 description 23
102000004889 Interleukin-6 Human genes 0.000 description 23
241001465754 Metazoa Species 0.000 description 21
230000002829 reductive effect Effects 0.000 description 21
238000004458 analytical method Methods 0.000 description 20
238000011476 stem cell transplantation Methods 0.000 description 19
102000003816 Interleukin-13 Human genes 0.000 description 18
108090000176 Interleukin-13 Proteins 0.000 description 18
POIUWJQBRNEFGX-XAMSXPGMSA-N cathelicidin Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C1=CC=CC=C1 POIUWJQBRNEFGX-XAMSXPGMSA-N 0.000 description 18
244000005709 gut microbiome Species 0.000 description 18
208000015181 infectious disease Diseases 0.000 description 18
241000699666 Mus <mouse, genus> Species 0.000 description 17
230000002354 daily effect Effects 0.000 description 17
230000000813 microbial effect Effects 0.000 description 17
102000004196 processed proteins & peptides Human genes 0.000 description 17
NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 16
208000002200 Respiratory Hypersensitivity Diseases 0.000 description 16
230000010085 airway hyperresponsiveness Effects 0.000 description 16
230000001580 bacterial effect Effects 0.000 description 16
108090000623 proteins and genes Proteins 0.000 description 16
239000003981 vehicle Substances 0.000 description 16
102000004388 Interleukin-4 Human genes 0.000 description 15
108090000978 Interleukin-4 Proteins 0.000 description 15
108010002616 Interleukin-5 Proteins 0.000 description 15
102000000743 Interleukin-5 Human genes 0.000 description 15
108010002335 Interleukin-9 Proteins 0.000 description 15
102000000585 Interleukin-9 Human genes 0.000 description 15
230000006378 damage Effects 0.000 description 15
108010074328 Interferon-gamma Proteins 0.000 description 14
102000003814 Interleukin-10 Human genes 0.000 description 14
108090000174 Interleukin-10 Proteins 0.000 description 14
239000002671 adjuvant Substances 0.000 description 14
206010009887 colitis Diseases 0.000 description 14
230000007423 decrease Effects 0.000 description 14
230000003247 decreasing effect Effects 0.000 description 14
201000010099 disease Diseases 0.000 description 14
230000007413 intestinal health Effects 0.000 description 14
239000008194 pharmaceutical composition Substances 0.000 description 14
239000000243 solution Substances 0.000 description 14
101000912247 Homo sapiens Beta-defensin 103 Proteins 0.000 description 13
102100037850 Interferon gamma Human genes 0.000 description 13
241000124008 Mammalia Species 0.000 description 13
150000002632 lipids Chemical class 0.000 description 13
230000009467 reduction Effects 0.000 description 13
238000006722 reduction reaction Methods 0.000 description 13
210000000952 spleen Anatomy 0.000 description 13
230000000845 anti-microbial effect Effects 0.000 description 12
230000014509 gene expression Effects 0.000 description 12
239000002502 liposome Substances 0.000 description 12
230000004199 lung function Effects 0.000 description 12
238000006467 substitution reaction Methods 0.000 description 12
101001041589 Homo sapiens Defensin-5 Proteins 0.000 description 11
230000016396 cytokine production Effects 0.000 description 11
230000018109 developmental process Effects 0.000 description 11
239000000463 material Substances 0.000 description 11
230000008774 maternal effect Effects 0.000 description 11
244000005700 microbiome Species 0.000 description 11
206010070545 Bacterial translocation Diseases 0.000 description 10
101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 description 10
102000003896 Myeloperoxidases Human genes 0.000 description 10
108090000235 Myeloperoxidases Proteins 0.000 description 10
125000003275 alpha amino acid group Chemical group 0.000 description 10
230000007375 bacterial translocation Effects 0.000 description 10
102000055647 human CSF2RB Human genes 0.000 description 10
210000000066 myeloid cell Anatomy 0.000 description 10
238000002360 preparation method Methods 0.000 description 10
235000018102 proteins Nutrition 0.000 description 10
102000004169 proteins and genes Human genes 0.000 description 10
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
108010023925 Histone Deacetylase 6 Proteins 0.000 description 9
102100022537 Histone deacetylase 6 Human genes 0.000 description 9
101001018100 Homo sapiens Lysozyme C Proteins 0.000 description 9
208000005107 Premature Birth Diseases 0.000 description 9
230000015572 biosynthetic process Effects 0.000 description 9
235000020256 human milk Nutrition 0.000 description 9
210000004251 human milk Anatomy 0.000 description 9
230000001123 neurodevelopmental effect Effects 0.000 description 9
229910052757 nitrogen Inorganic materials 0.000 description 9
230000035935 pregnancy Effects 0.000 description 9
230000002028 premature Effects 0.000 description 9
210000003491 skin Anatomy 0.000 description 9
241000927512 Barnesiella Species 0.000 description 8
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 8
108010036949 Cyclosporine Proteins 0.000 description 8
230000008859 change Effects 0.000 description 8
229960001265 ciclosporin Drugs 0.000 description 8
229930182912 cyclosporin Natural products 0.000 description 8
230000007123 defense Effects 0.000 description 8
239000012530 fluid Substances 0.000 description 8
229910052739 hydrogen Inorganic materials 0.000 description 8
230000008595 infiltration Effects 0.000 description 8
238000001764 infiltration Methods 0.000 description 8
210000004969 inflammatory cell Anatomy 0.000 description 8
230000002757 inflammatory effect Effects 0.000 description 8
229920001184 polypeptide Polymers 0.000 description 8
108010008165 Etanercept Proteins 0.000 description 7
101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 7
101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 7
101000798114 Homo sapiens Lactotransferrin Proteins 0.000 description 7
102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 7
229940073621 enbrel Drugs 0.000 description 7
238000009472 formulation Methods 0.000 description 7
102000048466 human DEFA5 Human genes 0.000 description 7
102000055779 human DEFB103A Human genes 0.000 description 7
102000050459 human LTF Human genes 0.000 description 7
210000004379 membrane Anatomy 0.000 description 7
239000012528 membrane Substances 0.000 description 7
239000000126 substance Substances 0.000 description 7
208000024891 symptom Diseases 0.000 description 7
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
102100026887 Beta-defensin 103 Human genes 0.000 description 6
241001430332 Bifidobacteriaceae Species 0.000 description 6
108090001007 Interleukin-8 Proteins 0.000 description 6
102000004890 Interleukin-8 Human genes 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
239000002202 Polyethylene glycol Substances 0.000 description 6
201000009961 allergic asthma Diseases 0.000 description 6
238000000540 analysis of variance Methods 0.000 description 6
210000001035 gastrointestinal tract Anatomy 0.000 description 6
210000002175 goblet cell Anatomy 0.000 description 6
230000036039 immunity Effects 0.000 description 6
210000004347 intestinal mucosa Anatomy 0.000 description 6
208000018773 low birth weight Diseases 0.000 description 6
235000013336 milk Nutrition 0.000 description 6
210000004080 milk Anatomy 0.000 description 6
239000008267 milk Substances 0.000 description 6
201000002652 newborn respiratory distress syndrome Diseases 0.000 description 6
244000052769 pathogen Species 0.000 description 6
239000000546 pharmaceutical excipient Substances 0.000 description 6
229920001223 polyethylene glycol Polymers 0.000 description 6
230000003389 potentiating effect Effects 0.000 description 6
239000000843 powder Substances 0.000 description 6
159000000000 sodium salts Chemical class 0.000 description 6
239000000725 suspension Substances 0.000 description 6
238000011269 treatment regimen Methods 0.000 description 6
238000005406 washing Methods 0.000 description 6
230000004580 weight loss Effects 0.000 description 6
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
208000009329 Graft vs Host Disease Diseases 0.000 description 5
101000899255 Homo sapiens Histone deacetylase 5 Proteins 0.000 description 5
101000918983 Homo sapiens Neutrophil defensin 1 Proteins 0.000 description 5
208000032571 Infant acute respiratory distress syndrome Diseases 0.000 description 5
125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 5
206010028851 Necrosis Diseases 0.000 description 5
206010028974 Neonatal respiratory distress syndrome Diseases 0.000 description 5
102100029494 Neutrophil defensin 1 Human genes 0.000 description 5
208000027418 Wounds and injury Diseases 0.000 description 5
230000003110 anti-inflammatory effect Effects 0.000 description 5
239000007864 aqueous solution Substances 0.000 description 5
210000000038 chest Anatomy 0.000 description 5
210000003022 colostrum Anatomy 0.000 description 5
235000021277 colostrum Nutrition 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
230000002550 fecal effect Effects 0.000 description 5
208000024908 graft versus host disease Diseases 0.000 description 5
208000014674 injury Diseases 0.000 description 5
239000007788 liquid Substances 0.000 description 5
231100000533 low birth weight Toxicity 0.000 description 5
230000017074 necrotic cell death Effects 0.000 description 5
238000010606 normalization Methods 0.000 description 5
238000003305 oral gavage Methods 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
KRJOFJHOZZPBKI-KSWODRSDSA-N α-defensin-1 Chemical compound C([C@H]1C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=4C=CC(O)=CC=4)NC(=O)[C@H](CSSC[C@H](NC2=O)C(O)=O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](C)C(=O)N3)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](C)C(=O)N1)[C@@H](C)CC)[C@@H](C)O)=O)[C@@H](C)CC)C1=CC=CC=C1 KRJOFJHOZZPBKI-KSWODRSDSA-N 0.000 description 5
241000731710 Allobaculum Species 0.000 description 4
241000521092 Alloprevotella Species 0.000 description 4
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 4
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 4
102000017761 Interleukin-33 Human genes 0.000 description 4
108010067003 Interleukin-33 Proteins 0.000 description 4
241000588748 Klebsiella Species 0.000 description 4
241000588747 Klebsiella pneumoniae Species 0.000 description 4
208000019693 Lung disease Diseases 0.000 description 4
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 4
206010042938 Systemic candida Diseases 0.000 description 4
125000000539 amino acid group Chemical group 0.000 description 4
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
239000000872 buffer Substances 0.000 description 4
210000004899 c-terminal region Anatomy 0.000 description 4
230000012292 cell migration Effects 0.000 description 4
206010008129 cerebral palsy Diseases 0.000 description 4
238000012512 characterization method Methods 0.000 description 4
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
230000001684 chronic effect Effects 0.000 description 4
238000007796 conventional method Methods 0.000 description 4
210000000805 cytoplasm Anatomy 0.000 description 4
230000034994 death Effects 0.000 description 4
231100000517 death Toxicity 0.000 description 4
230000006735 deficit Effects 0.000 description 4
235000021196 dietary intervention Nutrition 0.000 description 4
230000001079 digestive effect Effects 0.000 description 4
230000002255 enzymatic effect Effects 0.000 description 4
235000012631 food intake Nutrition 0.000 description 4
208000027866 inflammatory disease Diseases 0.000 description 4
230000028709 inflammatory response Effects 0.000 description 4
230000003871 intestinal function Effects 0.000 description 4
230000004207 intestinal integrity Effects 0.000 description 4
208000036732 invasive candidiasis Diseases 0.000 description 4
230000035800 maturation Effects 0.000 description 4
238000002703 mutagenesis Methods 0.000 description 4
231100000350 mutagenesis Toxicity 0.000 description 4
GRZXCHIIZXMEPJ-HTLKCAKFSA-N neutrophil peptide-2 Chemical compound C([C@H]1C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=4C=CC(O)=CC=4)NC(=O)[C@@H](N)CSSC[C@H](NC2=O)C(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](C)C(=O)N3)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](C)C(=O)N1)[C@@H](C)CC)[C@@H](C)O)=O)[C@@H](C)CC)C1=CC=CC=C1 GRZXCHIIZXMEPJ-HTLKCAKFSA-N 0.000 description 4
229910052760 oxygen Inorganic materials 0.000 description 4
239000001301 oxygen Substances 0.000 description 4
210000003134 paneth cell Anatomy 0.000 description 4
239000012188 paraffin wax Substances 0.000 description 4
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 4
229910052700 potassium Inorganic materials 0.000 description 4
239000000047 product Substances 0.000 description 4
230000000770 proinflammatory effect Effects 0.000 description 4
230000001953 sensory effect Effects 0.000 description 4
241000894007 species Species 0.000 description 4
229910052717 sulfur Inorganic materials 0.000 description 4
230000007704 transition Effects 0.000 description 4
230000003442 weekly effect Effects 0.000 description 4
230000004584 weight gain Effects 0.000 description 4
235000019786 weight gain Nutrition 0.000 description 4
239000008096 xylene Substances 0.000 description 4
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
101710193393 Alpha-defensin 5 Proteins 0.000 description 3
206010002091 Anaesthesia Diseases 0.000 description 3
208000034309 Bacterial disease carrier Diseases 0.000 description 3
241000186000 Bifidobacterium Species 0.000 description 3
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
238000002965 ELISA Methods 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
208000032843 Hemorrhage Diseases 0.000 description 3
101000929203 Homo sapiens Neutrophil defensin 4 Proteins 0.000 description 3
206010020751 Hypersensitivity Diseases 0.000 description 3
PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 3
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
125000000570 L-alpha-aspartyl group Chemical group [H]OC(=O)C([H])([H])[C@]([H])(N([H])[H])C(*)=O 0.000 description 3
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
208000036626 Mental retardation Diseases 0.000 description 3
101800000287 Neutrophil defensin 2 Proteins 0.000 description 3
102100036348 Neutrophil defensin 4 Human genes 0.000 description 3
235000003140 Panax quinquefolius Nutrition 0.000 description 3
240000005373 Panax quinquefolius Species 0.000 description 3
208000006399 Premature Obstetric Labor Diseases 0.000 description 3
206010036600 Premature labour Diseases 0.000 description 3
230000002159 abnormal effect Effects 0.000 description 3
239000000443 aerosol Substances 0.000 description 3
235000004279 alanine Nutrition 0.000 description 3
208000026935 allergic disease Diseases 0.000 description 3
230000007815 allergy Effects 0.000 description 3
230000037005 anaesthesia Effects 0.000 description 3
210000004082 barrier epithelial cell Anatomy 0.000 description 3
230000004071 biological effect Effects 0.000 description 3
230000000903 blocking effect Effects 0.000 description 3
210000000988 bone and bone Anatomy 0.000 description 3
210000001185 bone marrow Anatomy 0.000 description 3
208000029028 brain injury Diseases 0.000 description 3
229910052799 carbon Inorganic materials 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
238000011072 cell harvest Methods 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
230000009089 cytolysis Effects 0.000 description 3
230000007812 deficiency Effects 0.000 description 3
239000003085 diluting agent Substances 0.000 description 3
239000003937 drug carrier Substances 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
210000002745 epiphysis Anatomy 0.000 description 3
230000004890 epithelial barrier function Effects 0.000 description 3
210000002919 epithelial cell Anatomy 0.000 description 3
238000011156 evaluation Methods 0.000 description 3
210000003754 fetus Anatomy 0.000 description 3
238000002509 fluorescent in situ hybridization Methods 0.000 description 3
239000000499 gel Substances 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
239000008187 granular material Substances 0.000 description 3
102000046975 human DEFB1 Human genes 0.000 description 3
102000018475 human neutrophil peptide 2 Human genes 0.000 description 3
210000002865 immune cell Anatomy 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
238000011534 incubation Methods 0.000 description 3
230000004968 inflammatory condition Effects 0.000 description 3
230000004941 influx Effects 0.000 description 3
210000005007 innate immune system Anatomy 0.000 description 3
230000005694 interleukin-22 production Effects 0.000 description 3
230000007358 intestinal barrier function Effects 0.000 description 3
229960002725 isoflurane Drugs 0.000 description 3
210000003141 lower extremity Anatomy 0.000 description 3
238000002826 magnetic-activated cell sorting Methods 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
239000000693 micelle Substances 0.000 description 3
210000004877 mucosa Anatomy 0.000 description 3
210000003097 mucus Anatomy 0.000 description 3
238000007911 parenteral administration Methods 0.000 description 3
230000009984 peri-natal effect Effects 0.000 description 3
150000003904 phospholipids Chemical class 0.000 description 3
BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 3
208000026440 premature labor Diseases 0.000 description 3
230000008569 process Effects 0.000 description 3
102000005962 receptors Human genes 0.000 description 3
108020003175 receptors Proteins 0.000 description 3
238000011160 research Methods 0.000 description 3
230000003248 secreting effect Effects 0.000 description 3
230000028327 secretion Effects 0.000 description 3
238000000926 separation method Methods 0.000 description 3
210000002027 skeletal muscle Anatomy 0.000 description 3
239000002904 solvent Substances 0.000 description 3
230000009469 supplementation Effects 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
231100000419 toxicity Toxicity 0.000 description 3
230000001988 toxicity Effects 0.000 description 3
210000003437 trachea Anatomy 0.000 description 3
238000002054 transplantation Methods 0.000 description 3
238000009423 ventilation Methods 0.000 description 3
238000005303 weighing Methods 0.000 description 3
SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 2
KWVJHCQQUFDPLU-YEUCEMRASA-N 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KWVJHCQQUFDPLU-YEUCEMRASA-N 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
206010000060 Abdominal distension Diseases 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
241000702460 Akkermansia Species 0.000 description 2
BHELIUBJHYAEDK-OAIUPTLZSA-N Aspoxicillin Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3[C@H](C(C)(C)S[C@@H]32)C(O)=O)=O)NC(=O)[C@H](N)CC(=O)NC)=CC=C(O)C=C1 BHELIUBJHYAEDK-OAIUPTLZSA-N 0.000 description 2
101000798100 Bos taurus Lactotransferrin Proteins 0.000 description 2
FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 2
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
102100026549 Caspase-10 Human genes 0.000 description 2
102100038918 Caspase-6 Human genes 0.000 description 2
102100038902 Caspase-7 Human genes 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
102000011022 Chorionic Gonadotropin Human genes 0.000 description 2
108010062540 Chorionic Gonadotropin Proteins 0.000 description 2
241000193403 Clostridium Species 0.000 description 2
241001464948 Coprococcus Species 0.000 description 2
229940123719 Defensin agonist Drugs 0.000 description 2
208000027244 Dysbiosis Diseases 0.000 description 2
208000037487 Endotoxemia Diseases 0.000 description 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
241001608234 Faecalibacterium Species 0.000 description 2
241000192125 Firmicutes Species 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
241000282412 Homo Species 0.000 description 2
101000983518 Homo sapiens Caspase-10 Proteins 0.000 description 2
101000741014 Homo sapiens Caspase-7 Proteins 0.000 description 2
101000865479 Homo sapiens Defensin-6 Proteins 0.000 description 2
101000830386 Homo sapiens Neutrophil defensin 3 Proteins 0.000 description 2
108091006905 Human Serum Albumin Proteins 0.000 description 2
102000008100 Human Serum Albumin Human genes 0.000 description 2
206010020565 Hyperaemia Diseases 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 description 2
125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 description 2
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
241001468155 Lactobacillaceae Species 0.000 description 2
241000186660 Lactobacillus Species 0.000 description 2
102400000839 Lactoferricin-H Human genes 0.000 description 2
101800004366 Lactoferricin-H Proteins 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
239000004472 Lysine Substances 0.000 description 2
101150104680 MCH1 gene Proteins 0.000 description 2
101710089759 Melanin-concentrating hormone receptor 2 Proteins 0.000 description 2
206010054949 Metaplasia Diseases 0.000 description 2
101000648740 Mus musculus Tumor necrosis factor Proteins 0.000 description 2
102100024761 Neutrophil defensin 3 Human genes 0.000 description 2
206010051986 Pneumatosis Diseases 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
241000605861 Prevotella Species 0.000 description 2
101100382379 Rattus norvegicus Cap1 gene Proteins 0.000 description 2
241001591005 Siga Species 0.000 description 2
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
241001148134 Veillonella Species 0.000 description 2
206010072731 White matter lesion Diseases 0.000 description 2
230000009435 amidation Effects 0.000 description 2
238000007112 amidation reaction Methods 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
150000003863 ammonium salts Chemical class 0.000 description 2
230000000844 anti-bacterial effect Effects 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
239000004599 antimicrobial Substances 0.000 description 2
230000001588 bifunctional effect Effects 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
238000010322 bone marrow transplantation Methods 0.000 description 2
229940072440 bovine lactoferrin Drugs 0.000 description 2
125000002091 cationic group Chemical group 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
235000012000 cholesterol Nutrition 0.000 description 2
229940015047 chorionic gonadotropin Drugs 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
239000003246 corticosteroid Substances 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
239000003599 detergent Substances 0.000 description 2
230000029087 digestion Effects 0.000 description 2
230000009266 disease activity Effects 0.000 description 2
230000007140 dysbiosis Effects 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
239000002158 endotoxin Substances 0.000 description 2
235000020776 essential amino acid Nutrition 0.000 description 2
239000003797 essential amino acid Substances 0.000 description 2
230000001605 fetal effect Effects 0.000 description 2
235000013305 food Nutrition 0.000 description 2
150000003948 formamides Chemical class 0.000 description 2
230000006870 function Effects 0.000 description 2
210000003714 granulocyte Anatomy 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
210000003128 head Anatomy 0.000 description 2
235000014304 histidine Nutrition 0.000 description 2
230000007540 host microbe interaction Effects 0.000 description 2
238000009396 hybridization Methods 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
230000004047 hyperresponsiveness Effects 0.000 description 2
230000028993 immune response Effects 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
230000006698 induction Effects 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
230000015788 innate immune response Effects 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
210000005027 intestinal barrier Anatomy 0.000 description 2
208000028774 intestinal disease Diseases 0.000 description 2
210000002490 intestinal epithelial cell Anatomy 0.000 description 2
210000005206 intestinal lamina propria Anatomy 0.000 description 2
230000004673 intestinal mucosal barrier function Effects 0.000 description 2
230000003870 intestinal permeability Effects 0.000 description 2
238000007912 intraperitoneal administration Methods 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
230000006651 lactation Effects 0.000 description 2
210000002429 large intestine Anatomy 0.000 description 2
230000003902 lesion Effects 0.000 description 2
230000007774 longterm Effects 0.000 description 2
230000007040 lung development Effects 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
238000005399 mechanical ventilation Methods 0.000 description 2
238000002483 medication Methods 0.000 description 2
230000015689 metaplastic ossification Effects 0.000 description 2
229940071648 metered dose inhaler Drugs 0.000 description 2
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
210000000110 microvilli Anatomy 0.000 description 2
230000004678 mucosal integrity Effects 0.000 description 2
239000002105 nanoparticle Substances 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
235000016709 nutrition Nutrition 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
235000016236 parenteral nutrition Nutrition 0.000 description 2
230000008506 pathogenesis Effects 0.000 description 2
230000037361 pathway Effects 0.000 description 2
201000005936 periventricular leukomalacia Diseases 0.000 description 2
230000035699 permeability Effects 0.000 description 2
210000002826 placenta Anatomy 0.000 description 2
229920002704 polyhistidine Polymers 0.000 description 2
239000002243 precursor Substances 0.000 description 2
230000003449 preventive effect Effects 0.000 description 2
230000009325 pulmonary function Effects 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000011552 rat model Methods 0.000 description 2
239000003642 reactive oxygen metabolite Substances 0.000 description 2
230000000241 respiratory effect Effects 0.000 description 2
230000029058 respiratory gaseous exchange Effects 0.000 description 2
230000004044 response Effects 0.000 description 2
210000003296 saliva Anatomy 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
230000007017 scission Effects 0.000 description 2
238000007493 shaping process Methods 0.000 description 2
150000004666 short chain fatty acids Chemical class 0.000 description 2
235000019333 sodium laurylsulphate Nutrition 0.000 description 2
239000007787 solid Substances 0.000 description 2
125000006850 spacer group Chemical group 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
238000007619 statistical method Methods 0.000 description 2
210000000130 stem cell Anatomy 0.000 description 2
210000002784 stomach Anatomy 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
231100000057 systemic toxicity Toxicity 0.000 description 2
239000003826 tablet Substances 0.000 description 2
210000001138 tear Anatomy 0.000 description 2
150000003568 thioethers Chemical class 0.000 description 2
229940034610 toothpaste Drugs 0.000 description 2
239000000606 toothpaste Substances 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
230000000007 visual effect Effects 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
210000004885 white matter Anatomy 0.000 description 2
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
VZQHRKZCAZCACO-PYJNHQTQSA-N (2s)-2-[[(2s)-2-[2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]prop-2-enoylamino]-3-methylbutanoyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VZQHRKZCAZCACO-PYJNHQTQSA-N 0.000 description 1
OCUSNPIJIZCRSZ-ZTZWCFDHSA-N (2s)-2-amino-3-methylbutanoic acid;(2s)-2-amino-4-methylpentanoic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound CC(C)[C@H](N)C(O)=O.CC[C@H](C)[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O OCUSNPIJIZCRSZ-ZTZWCFDHSA-N 0.000 description 1
JQFLYFRHDIHZFZ-RXMQYKEDSA-N (2s)-3,3-dimethylpyrrolidine-2-carboxylic acid Chemical compound CC1(C)CCN[C@@H]1C(O)=O JQFLYFRHDIHZFZ-RXMQYKEDSA-N 0.000 description 1
CNPSFBUUYIVHAP-AKGZTFGVSA-N (2s)-3-methylpyrrolidine-2-carboxylic acid Chemical compound CC1CCN[C@@H]1C(O)=O CNPSFBUUYIVHAP-AKGZTFGVSA-N 0.000 description 1
FVXDQWZBHIXIEJ-LNDKUQBDSA-N 1,2-di-[(9Z,12Z)-octadecadienoyl]-sn-glycero-3-phosphocholine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC FVXDQWZBHIXIEJ-LNDKUQBDSA-N 0.000 description 1
SLKDGVPOSSLUAI-PGUFJCEWSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine zwitterion Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCCCCCC SLKDGVPOSSLUAI-PGUFJCEWSA-N 0.000 description 1
KLFKZIQAIPDJCW-GPOMZPHUSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCC KLFKZIQAIPDJCW-GPOMZPHUSA-N 0.000 description 1
DSNRWDQKZIEDDB-SQYFZQSCSA-N 1,2-dioleoyl-sn-glycero-3-phospho-(1'-sn-glycerol) Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@@H](O)CO)OC(=O)CCCCCCC\C=C/CCCCCCCC DSNRWDQKZIEDDB-SQYFZQSCSA-N 0.000 description 1
WTBFLCSPLLEDEM-JIDRGYQWSA-N 1,2-dioleoyl-sn-glycero-3-phospho-L-serine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC WTBFLCSPLLEDEM-JIDRGYQWSA-N 0.000 description 1
MWRBNPKJOOWZPW-NYVOMTAGSA-N 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine zwitterion Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CCCCCCC\C=C/CCCCCCCC MWRBNPKJOOWZPW-NYVOMTAGSA-N 0.000 description 1
MHUWZNTUIIFHAS-DSSVUWSHSA-N 1,2-dioleoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-DSSVUWSHSA-N 0.000 description 1
NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 description 1
UOFGSWVZMUXXIY-UHFFFAOYSA-N 1,5-Diphenyl-3-thiocarbazone Chemical compound C=1C=CC=CC=1N=NC(=S)NNC1=CC=CC=C1 UOFGSWVZMUXXIY-UHFFFAOYSA-N 0.000 description 1
CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
XXCVIFJHBFNFBO-UHFFFAOYSA-N 1-ethenoxyoctane Chemical group CCCCCCCCOC=C XXCVIFJHBFNFBO-UHFFFAOYSA-N 0.000 description 1
OMGHIGVFLOPEHJ-UHFFFAOYSA-N 2,5-dihydro-1h-pyrrol-1-ium-2-carboxylate Chemical compound OC(=O)C1NCC=C1 OMGHIGVFLOPEHJ-UHFFFAOYSA-N 0.000 description 1
TXLHNFOLHRXMAU-UHFFFAOYSA-N 2-(4-benzylphenoxy)-n,n-diethylethanamine;hydron;chloride Chemical compound Cl.C1=CC(OCCN(CC)CC)=CC=C1CC1=CC=CC=C1 TXLHNFOLHRXMAU-UHFFFAOYSA-N 0.000 description 1
FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 1
HNLXNOZHXNSSPN-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCOCCOCCOCCO)C=C1 HNLXNOZHXNSSPN-UHFFFAOYSA-N 0.000 description 1
CDUUKBXTEOFITR-BYPYZUCNSA-N 2-methyl-L-serine Chemical compound OC[C@@]([NH3+])(C)C([O-])=O CDUUKBXTEOFITR-BYPYZUCNSA-N 0.000 description 1
NITXODYAMWZEJY-UHFFFAOYSA-N 3-(pyridin-2-yldisulfanyl)propanehydrazide Chemical compound NNC(=O)CCSSC1=CC=CC=N1 NITXODYAMWZEJY-UHFFFAOYSA-N 0.000 description 1
TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 1
CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
108091061348 AMP family Proteins 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
206010060937 Amniotic cavity infection Diseases 0.000 description 1
241000203069 Archaea Species 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
241001625917 Aulostomidae Species 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
241000605059 Bacteroidetes Species 0.000 description 1
241000868590 Barnesiellaceae Species 0.000 description 1
241001655328 Bifidobacteriales Species 0.000 description 1
241001202853 Blautia Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 1
238000011746 C57BL/6J (JAX™ mouse strain) Methods 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
241000222120 Candida <Saccharomycetales> Species 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
206010007134 Candida infections Diseases 0.000 description 1
208000004652 Cardiovascular Abnormalities Diseases 0.000 description 1
208000022306 Cerebral injury Diseases 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
208000008158 Chorioamnionitis Diseases 0.000 description 1
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
206010009900 Colitis ulcerative Diseases 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
206010010356 Congenital anomaly Diseases 0.000 description 1
241000186216 Corynebacterium Species 0.000 description 1
208000011231 Crohn disease Diseases 0.000 description 1
201000003883 Cystic fibrosis Diseases 0.000 description 1
AGPKZVBTJJNPAG-RFZPGFLSSA-N D-Isoleucine Chemical compound CC[C@@H](C)[C@@H](N)C(O)=O AGPKZVBTJJNPAG-RFZPGFLSSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
229930182845 D-isoleucine Natural products 0.000 description 1
108020004414 DNA Proteins 0.000 description 1
101710178508 Defensin 3 Proteins 0.000 description 1
102100021420 Defensin-5 Human genes 0.000 description 1
102100029790 Defensin-6 Human genes 0.000 description 1
208000005156 Dehydration Diseases 0.000 description 1
208000034423 Delivery Diseases 0.000 description 1
206010012741 Diarrhoea haemorrhagic Diseases 0.000 description 1
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
GZDFHIJNHHMENY-UHFFFAOYSA-N Dimethyl dicarbonate Chemical compound COC(=O)OC(=O)OC GZDFHIJNHHMENY-UHFFFAOYSA-N 0.000 description 1
102100025137 Early activation antigen CD69 Human genes 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
241000186394 Eubacterium Species 0.000 description 1
102000009109 Fc receptors Human genes 0.000 description 1
108010087819 Fc receptors Proteins 0.000 description 1
241000233866 Fungi Species 0.000 description 1
241001453172 Fusobacteria Species 0.000 description 1
206010017982 Gastrointestinal necrosis Diseases 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
241000606790 Haemophilus Species 0.000 description 1
241000282418 Hominidae Species 0.000 description 1
101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 1
101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 1
208000000203 Hyaline Membrane Disease Diseases 0.000 description 1
102000004157 Hydrolases Human genes 0.000 description 1
108090000604 Hydrolases Proteins 0.000 description 1
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
206010055171 Hypertensive nephropathy Diseases 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
208000032754 Infant Death Diseases 0.000 description 1
206010021882 Infections and infestations congenital Diseases 0.000 description 1
208000022559 Inflammatory bowel disease Diseases 0.000 description 1
108010014726 Interferon Type I Proteins 0.000 description 1
102000002227 Interferon Type I Human genes 0.000 description 1
108010002352 Interleukin-1 Proteins 0.000 description 1
102000000589 Interleukin-1 Human genes 0.000 description 1
201000008225 Klebsiella pneumonia Diseases 0.000 description 1
WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
125000001176 L-lysyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C([H])([H])C(N([H])[H])([H])[H] 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
HXEACLLIILLPRG-YFKPBYRVSA-N L-pipecolic acid Chemical compound [O-]C(=O)[C@@H]1CCCC[NH2+]1 HXEACLLIILLPRG-YFKPBYRVSA-N 0.000 description 1
DZLNHFMRPBPULJ-VKHMYHEASA-N L-thioproline Chemical compound OC(=O)[C@@H]1CSCN1 DZLNHFMRPBPULJ-VKHMYHEASA-N 0.000 description 1
125000000769 L-threonyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](O[H])(C([H])([H])[H])[H] 0.000 description 1
KKJQZEWNZXRJFG-UHFFFAOYSA-N L-trans-4-Methyl-2-pyrrolidinecarboxylic acid Chemical compound CC1CNC(C(O)=O)C1 KKJQZEWNZXRJFG-UHFFFAOYSA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
125000003798 L-tyrosyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 description 1
241001134638 Lachnospira Species 0.000 description 1
241000218588 Lactobacillus rhamnosus Species 0.000 description 1
239000000232 Lipid Bilayer Substances 0.000 description 1
235000000060 Malva neglecta Nutrition 0.000 description 1
240000000982 Malva neglecta Species 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
241000202987 Methanobrevibacter Species 0.000 description 1
108010063954 Mucins Proteins 0.000 description 1
102000015728 Mucins Human genes 0.000 description 1
208000034486 Multi-organ failure Diseases 0.000 description 1
208000010718 Multiple Organ Failure Diseases 0.000 description 1
MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
101000870674 Mus musculus Beta-defensin 3 Proteins 0.000 description 1
PQNASZJZHFPQLE-LURJTMIESA-N N(6)-methyl-L-lysine Chemical compound CNCCCC[C@H](N)C(O)=O PQNASZJZHFPQLE-LURJTMIESA-N 0.000 description 1
MNLRQHMNZILYPY-MDMHTWEWSA-N N-acetyl-alpha-D-muramic acid Chemical compound OC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](O)[C@@H]1NC(C)=O MNLRQHMNZILYPY-MDMHTWEWSA-N 0.000 description 1
OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
241000588653 Neisseria Species 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
108091028043 Nucleic acid sequence Proteins 0.000 description 1
SUHOOTKUPISOBE-UHFFFAOYSA-N O-phosphoethanolamine Chemical compound NCCOP(O)(O)=O SUHOOTKUPISOBE-UHFFFAOYSA-N 0.000 description 1
206010030113 Oedema Diseases 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
101100274508 Oryza sativa subsp. japonica CKI1 gene Proteins 0.000 description 1
206010033078 Otitis media Diseases 0.000 description 1
KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 description 1
206010033546 Pallor Diseases 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
101710176384 Peptide 1 Proteins 0.000 description 1
108010013639 Peptidoglycan Proteins 0.000 description 1
206010034568 Peripheral coldness Diseases 0.000 description 1
241000425347 Phyla <beetle> Species 0.000 description 1
206010035717 Pneumonia klebsiella Diseases 0.000 description 1
RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
241000605894 Porphyromonas Species 0.000 description 1
241000692844 Prevotellaceae Species 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
241000192142 Proteobacteria Species 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
101001041581 Rattus norvegicus Defensin 5 Proteins 0.000 description 1
241000605947 Roseburia Species 0.000 description 1
241001453443 Rothia <bacteria> Species 0.000 description 1
241000192031 Ruminococcus Species 0.000 description 1
238000011579 SCID mouse model Methods 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
102100039360 Toll-like receptor 4 Human genes 0.000 description 1
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
201000006704 Ulcerative Colitis Diseases 0.000 description 1
231100000230 acceptable toxicity Toxicity 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
229960000583 acetic acid Drugs 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
208000024340 acute graft versus host disease Diseases 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
230000003044 adaptive effect Effects 0.000 description 1
230000033289 adaptive immune response Effects 0.000 description 1
230000004721 adaptive immunity Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
238000013019 agitation Methods 0.000 description 1
208000037883 airway inflammation Diseases 0.000 description 1
230000009285 allergic inflammation Effects 0.000 description 1
229940087168 alpha tocopherol Drugs 0.000 description 1
CDUUKBXTEOFITR-UHFFFAOYSA-N alpha-methylserine Natural products OCC([NH3+])(C)C([O-])=O CDUUKBXTEOFITR-UHFFFAOYSA-N 0.000 description 1
238000010640 amide synthesis reaction Methods 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
210000004381 amniotic fluid Anatomy 0.000 description 1
238000010171 animal model Methods 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
230000006907 apoptotic process Effects 0.000 description 1
239000008365 aqueous carrier Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
238000004820 blood count Methods 0.000 description 1
238000010241 blood sampling Methods 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
210000000621 bronchi Anatomy 0.000 description 1
238000013276 bronchoscopy Methods 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
238000004422 calculation algorithm Methods 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
201000003984 candidiasis Diseases 0.000 description 1
239000002775 capsule Substances 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
239000000969 carrier Substances 0.000 description 1
210000004534 cecum Anatomy 0.000 description 1
239000013553 cell monolayer Substances 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
GLCFDMVVSSMZRL-BRKZGERCSA-N chembl499388 Chemical compound C([C@H]1C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=4C=CC(O)=CC=4)NC(=O)[C@H](CSSC[C@H](NC2=O)C(O)=O)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](C)C(=O)N3)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](C)C(=O)N1)[C@@H](C)CC)[C@@H](C)O)=O)[C@@H](C)CC)C1=CC=CC=C1 GLCFDMVVSSMZRL-BRKZGERCSA-N 0.000 description 1
238000012412 chemical coupling Methods 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
229940112822 chewing gum Drugs 0.000 description 1
235000015218 chewing gum Nutrition 0.000 description 1
150000003841 chloride salts Chemical class 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
230000007278 cognition impairment Effects 0.000 description 1
210000004953 colonic tissue Anatomy 0.000 description 1
230000002281 colonystimulating effect Effects 0.000 description 1
238000002648 combination therapy Methods 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
230000001268 conjugating effect Effects 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
235000020940 control diet Nutrition 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000000875 corresponding effect Effects 0.000 description 1
229960001334 corticosteroids Drugs 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
235000020247 cow milk Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
150000001945 cysteines Chemical class 0.000 description 1
210000004395 cytoplasmic granule Anatomy 0.000 description 1
230000001120 cytoprotective effect Effects 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
210000004443 dendritic cell Anatomy 0.000 description 1
229940009976 deoxycholate Drugs 0.000 description 1
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000013229 diet-induced obese mouse Methods 0.000 description 1
235000021045 dietary change Nutrition 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
BPHQZTVXXXJVHI-UHFFFAOYSA-N dimyristoyl phosphatidylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCC BPHQZTVXXXJVHI-UHFFFAOYSA-N 0.000 description 1
MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
BIABMEZBCHDPBV-UHFFFAOYSA-N dipalmitoyl phosphatidylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC BIABMEZBCHDPBV-UHFFFAOYSA-N 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
238000009826 distribution Methods 0.000 description 1
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000006196 drop Substances 0.000 description 1
229940112141 dry powder inhaler Drugs 0.000 description 1
210000003017 ductus arteriosus Anatomy 0.000 description 1
210000000959 ear middle Anatomy 0.000 description 1
230000002900 effect on cell Effects 0.000 description 1
239000012636 effector Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
230000010393 epithelial cell migration Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
238000013401 experimental design Methods 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
210000001723 extracellular space Anatomy 0.000 description 1
210000001508 eye Anatomy 0.000 description 1
238000005562 fading Methods 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
239000012091 fetal bovine serum Substances 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000000945 filler Substances 0.000 description 1
239000000834 fixative Substances 0.000 description 1
238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
235000014105 formulated food Nutrition 0.000 description 1
239000012634 fragment Substances 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
239000012520 frozen sample Substances 0.000 description 1
230000005714 functional activity Effects 0.000 description 1
230000000855 fungicidal effect Effects 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000012362 glacial acetic acid Substances 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
102000034238 globular proteins Human genes 0.000 description 1
108091005896 globular proteins Proteins 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
244000000058 gram-negative pathogen Species 0.000 description 1
210000002216 heart Anatomy 0.000 description 1
230000011132 hemopoiesis Effects 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
150000002411 histidines Chemical class 0.000 description 1
230000036732 histological change Effects 0.000 description 1
230000003284 homeostatic effect Effects 0.000 description 1
102000050514 human DEFA6 Human genes 0.000 description 1
230000000887 hydrating effect Effects 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
229960002591 hydroxyproline Drugs 0.000 description 1
206010020718 hyperplasia Diseases 0.000 description 1
230000001146 hypoxic effect Effects 0.000 description 1
230000007124 immune defense Effects 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000008629 immune suppression Effects 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
238000013388 immunohistochemistry analysis Methods 0.000 description 1
229940088592 immunologic factor Drugs 0.000 description 1
239000000367 immunologic factor Substances 0.000 description 1
230000004957 immunoregulator effect Effects 0.000 description 1
238000012744 immunostaining Methods 0.000 description 1
238000002650 immunosuppressive therapy Methods 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
239000011261 inert gas Substances 0.000 description 1
230000008944 intestinal immunity Effects 0.000 description 1
238000009263 intestinal permeability test Methods 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
239000000644 isotonic solution Substances 0.000 description 1
GCHPUFAZSONQIV-UHFFFAOYSA-N isovaline Chemical compound CCC(C)(N)C(O)=O GCHPUFAZSONQIV-UHFFFAOYSA-N 0.000 description 1
210000004731 jugular vein Anatomy 0.000 description 1
HXEACLLIILLPRG-RXMQYKEDSA-N l-pipecolic acid Natural products OC(=O)[C@H]1CCCCN1 HXEACLLIILLPRG-RXMQYKEDSA-N 0.000 description 1
238000002372 labelling Methods 0.000 description 1
229940039696 lactobacillus Drugs 0.000 description 1
JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
229960000511 lactulose Drugs 0.000 description 1
PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
229960004502 levodopa Drugs 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
230000004807 localization Effects 0.000 description 1
230000005923 long-lasting effect Effects 0.000 description 1
230000008376 long-term health Effects 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
230000032646 lung growth Effects 0.000 description 1
239000003580 lung surfactant Substances 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
210000003712 lysosome Anatomy 0.000 description 1
230000001868 lysosomic effect Effects 0.000 description 1
108700025647 major vault Proteins 0.000 description 1
210000005075 mammary gland Anatomy 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
239000003550 marker Substances 0.000 description 1
210000003622 mature neutrocyte Anatomy 0.000 description 1
210000001006 meconium Anatomy 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
229910021645 metal ion Inorganic materials 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
238000010208 microarray analysis Methods 0.000 description 1
239000013586 microbial product Substances 0.000 description 1
230000002906 microbiologic effect Effects 0.000 description 1
239000003094 microcapsule Substances 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
230000000116 mitigating effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
231100001228 moderately toxic Toxicity 0.000 description 1
239000003607 modifier Substances 0.000 description 1
239000012120 mounting media Substances 0.000 description 1
210000000214 mouth Anatomy 0.000 description 1
229940051875 mucins Drugs 0.000 description 1
208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
238000002887 multiple sequence alignment Methods 0.000 description 1
229940051921 muramidase Drugs 0.000 description 1
230000035772 mutation Effects 0.000 description 1
230000000926 neurological effect Effects 0.000 description 1
230000002887 neurotoxic effect Effects 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
229920002114 octoxynol-9 Polymers 0.000 description 1
229940098514 octoxynol-9 Drugs 0.000 description 1
230000008816 organ damage Effects 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
239000003002 pH adjusting agent Substances 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
231100000915 pathological change Toxicity 0.000 description 1
230000036285 pathological change Effects 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
230000003617 peroxidasic effect Effects 0.000 description 1
230000002688 persistence Effects 0.000 description 1
238000002823 phage display Methods 0.000 description 1
229940124531 pharmaceutical excipient Drugs 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
230000035479 physiological effects, processes and functions Effects 0.000 description 1
INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
238000013310 pig model Methods 0.000 description 1
229940068196 placebo Drugs 0.000 description 1
239000000902 placebo Substances 0.000 description 1
239000002985 plastic film Substances 0.000 description 1
229920001993 poloxamer 188 Polymers 0.000 description 1
229920001992 poloxamer 407 Polymers 0.000 description 1
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
229920001451 polypropylene glycol Polymers 0.000 description 1
229920000053 polysorbate 80 Polymers 0.000 description 1
230000034190 positive regulation of NF-kappaB transcription factor activity Effects 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
229960005205 prednisolone Drugs 0.000 description 1
OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
238000012545 processing Methods 0.000 description 1
238000004393 prognosis Methods 0.000 description 1
230000009465 prokaryotic expression Effects 0.000 description 1
239000003223 protective agent Substances 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
238000012383 pulmonary drug delivery Methods 0.000 description 1
210000004879 pulmonary tissue Anatomy 0.000 description 1
238000011002 quantification Methods 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
238000003259 recombinant expression Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
210000000664 rectum Anatomy 0.000 description 1
238000006268 reductive amination reaction Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
210000002345 respiratory system Anatomy 0.000 description 1
208000020029 respiratory tract infectious disease Diseases 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
239000000523 sample Substances 0.000 description 1
238000012216 screening Methods 0.000 description 1
229960001153 serine Drugs 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
235000021391 short chain fatty acids Nutrition 0.000 description 1
230000008591 skin barrier function Effects 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
230000000391 smoking effect Effects 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
239000001540 sodium lactate Substances 0.000 description 1
229940005581 sodium lactate Drugs 0.000 description 1
235000011088 sodium lactate Nutrition 0.000 description 1
FGGPAWQCCGEWTJ-UHFFFAOYSA-M sodium;2,3-bis(sulfanyl)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(S)CS FGGPAWQCCGEWTJ-UHFFFAOYSA-M 0.000 description 1
230000003381 solubilizing effect Effects 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
238000010972 statistical evaluation Methods 0.000 description 1
239000008174 sterile solution Substances 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000000153 supplemental effect Effects 0.000 description 1
230000001502 supplementing effect Effects 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
230000008685 targeting Effects 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
210000001578 tight junction Anatomy 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
229960000984 tocofersolan Drugs 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
230000014616 translation Effects 0.000 description 1
230000005945 translocation Effects 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
208000019206 urinary tract infection Diseases 0.000 description 1
210000002229 urogenital system Anatomy 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
210000001215 vagina Anatomy 0.000 description 1
230000009677 vaginal delivery Effects 0.000 description 1
230000002792 vascular Effects 0.000 description 1
230000005570 vertical transmission Effects 0.000 description 1
239000011534 wash buffer Substances 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
239000002076 α-tocopherol Substances 0.000 description 1
235000004835 α-tocopherol Nutrition 0.000 description 1